Supplemental Table 3 from Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population
Authors
Brendan M. Giles
Emma J. Crosbie (ORCID: https://orcid.org/0000-0003-0284-8630)
Benjamin G. Bitler (ORCID: https://orcid.org/0000-0002-5809-5271)
Connor Hansen
Anna Jeter (ORCID: https://orcid.org/0009-0002-9757-3536)
Supplemental Table 3 from Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population
Brendan M. Giles, Emma J. Crosbie, Benjamin G. Bitler, Connor Hansen et al.
Topics
Metabolomics and Mass Spectrometry Studies
article
Supplemental Table 3 from Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population
Brendan M. Giles, Emma J. Crosbie, Benjamin G. Bitler, Connor Hansen, Anna Jeter, Rachel Culp‐Hill, James R. White, Kian Behbakht, Emily C. Kubota, Robert Adger Law, Violeta Beleva Guthrie, Leonardo N. Hagmann, Abigail McElhinny, Vuna S. Fa, Charles M. Nichols, Enkhtuya Radnaa, Chloe E. Barr, Maria Pik Wong, Collin Hill, Moises Zapata, Melvyn Goldberg